Skyscape Web Viewer : CURRENT Practice Guidelines In Primary Care : Table Index

View All
Table 13-1 Clinical Recommendations For Use of Professionally Applied or Prescription-Strength, Home-Use Topical Fluoride Agents For Caries Prevention in Patients At Elevated Risk of Developing Caries
Table 13-3 Cutoffs For Pediatric Stage 1 Hypertension
Table 19-10 Impact of Health Behavior Management On Blood Pressure
Table 19-12 Screening BP Values Requiring Further Evaluation
Table 19-2 Rate Control in Atrial Fibrillation: Calcium Channel Blockers
Table 10-1 Stages of Acute Kidney Injury
Table 13-2 Recommended Fluoride Supplementation by Age and Fluoride Level in Community Water Supply
Table 15-1 Cervical Cancer Screening Recommendations
Table 19-11 Lifestyle Modifications For Treatment of Hypertension
Table 19-1 Rate Control in Atrial Fibrillation: Beta-Blockers
Table 19-3 Rate Control in Atrial Fibrillation: Cardiac Glycosides
Table 19-5 Stroke Risk Stratification with the Chads2 and Cha2ds2-Vasc Scores
Table 19-7 Thromboembolic Risk Scores in Nonvalvular Atrial Fibrillation
Table 19-9 Diabetes Medications with Cardiovascular Benefits
Table 20-1 Palliative and End-of-Life Care: Pain Management.
Table 21-1 Dosing and Monitoring of Antithyroid Drug Therapy
Table 21-3 International Panel Guideline On Selecting Sglt-2 Inhibitors or Glp-1 Receptor Agonists
Table 22-1 Acute Otitis Media—approaches to Treatment
Table 2-2 Statin Intensity Drug Levels
Table 2-3 Statin-Associated Side Effects
Table 24-2 Responses to Abnormal Screening Results, Patients Age 25-65 with Prior Anomaliesa
Table 24-4 Risk-Stratified Evaluation of Microscopic Hematuria
Table 24-6 Clinical Diagnosis of Vaginitis
Table 25-11 Selected Second-Line Therapy Options in Adult ITP
Table 25-2 Noninfectious Complications of Blood Transfusion
Table 25-4 Wells Score For DVT
Table 25-6 Recommended Anticoagulant Selection and Duration of Anticoagulation Based On Risk Factors and Location of DVT
Table 25-8 New Oral Anticoagulantsa and Warfarin
Table 26-1 Cdc Patient Risk Groups For Prioritizing COVID Therapy
Table 26-3 Comparison of Recommendations For Various Therapies in Nonsevere Disease, in the Non-Hospital Setting